These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 35848881)
41. Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition. Yagi H; Yotsumoto F; Miyamoto S Mol Cancer Ther; 2008 Oct; 7(10):3441-51. PubMed ID: 18852147 [TBL] [Abstract][Full Text] [Related]
42. Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway. Yoshihara M; Kajiyama H; Yokoi A; Sugiyama M; Koya Y; Yamakita Y; Liu W; Nakamura K; Moriyama Y; Yasui H; Suzuki S; Yamamoto Y; Ricciardelli C; Nawa A; Shibata K; Kikkawa F Int J Cancer; 2020 Apr; 146(8):2268-2280. PubMed ID: 31904865 [TBL] [Abstract][Full Text] [Related]
43. The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway. Ogishima J; Taguchi A; Kawata A; Kawana K; Yoshida M; Yoshimatsu Y; Sato M; Nakamura H; Kawata Y; Nishijima A; Fujimoto A; Tomio K; Adachi K; Nagamatsu T; Oda K; Kiyono T; Osuga Y; Fujii T BMC Cancer; 2018 Dec; 18(1):1201. PubMed ID: 30509235 [TBL] [Abstract][Full Text] [Related]
44. AEG -1 overexpression: a novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers. Li C; Liu J; Lu R; Yu G; Wang X; Zhao Y; Song H; Lin P; Sun X; Yu X; Zhang Y; Ning X; Geng J Int J Gynecol Cancer; 2011 May; 21(4):602-8. PubMed ID: 21543927 [TBL] [Abstract][Full Text] [Related]
45. Adhesion molecules and TGF-beta1 are involved in the peritoneal dissemination of NUGC-4 human gastric cancer cells. Nakashio T; Narita T; Akiyama S; Kasai Y; Kondo K; Ito K; Takagi H; Kannagi R Int J Cancer; 1997 Mar; 70(5):612-8. PubMed ID: 9052764 [TBL] [Abstract][Full Text] [Related]
46. Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase. Satpathy M; Cao L; Pincheira R; Emerson R; Bigsby R; Nakshatri H; Matei D Cancer Res; 2007 Aug; 67(15):7194-202. PubMed ID: 17671187 [TBL] [Abstract][Full Text] [Related]
48. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions. Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856 [TBL] [Abstract][Full Text] [Related]
49. Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways. Dayyani F; Parikh NU; Varkaris AS; Song JH; Moorthy S; Chatterji T; Maity SN; Wolfe AR; Carboni JM; Gottardis MM; Logothetis CJ; Gallick GE PLoS One; 2012; 7(12):e51189. PubMed ID: 23300537 [TBL] [Abstract][Full Text] [Related]
50. Activity of the multikinase inhibitor dasatinib against ovarian cancer cells. Konecny GE; Glas R; Dering J; Manivong K; Qi J; Finn RS; Yang GR; Hong KL; Ginther C; Winterhoff B; Gao G; Brugge J; Slamon DJ Br J Cancer; 2009 Nov; 101(10):1699-708. PubMed ID: 19861960 [TBL] [Abstract][Full Text] [Related]
51. In vitro mesothelial clearance assay that models the early steps of ovarian cancer metastasis. Davidowitz RA; Iwanicki MP; Brugge JS J Vis Exp; 2012 Feb; (60):. PubMed ID: 22371143 [TBL] [Abstract][Full Text] [Related]
52. Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: a review. Dhaliwal D; Shepherd TG Clin Exp Metastasis; 2022 Apr; 39(2):291-301. PubMed ID: 34822024 [TBL] [Abstract][Full Text] [Related]
53. Serotonin/HTR1E signaling blocks chronic stress-promoted progression of ovarian cancer. Qin X; Li J; Wang S; Lv J; Luan F; Liu Y; Chen Y; Chen X; Zhao Y; Zhu J; Piao Y; Zhang W; Shi Y; Xiang R; Qu P; Wang L Theranostics; 2021; 11(14):6950-6965. PubMed ID: 34093864 [No Abstract] [Full Text] [Related]
54. PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination. Peng Y; Kajiyama H; Yuan H; Nakamura K; Yoshihara M; Yokoi A; Fujikake K; Yasui H; Yoshikawa N; Suzuki S; Senga T; Shibata K; Kikkawa F Cancer Lett; 2019 Feb; 442():181-192. PubMed ID: 30429105 [TBL] [Abstract][Full Text] [Related]
56. Flow Cytometric Analysis of Ovarian Cancer Ascites: Response of Mesothelial Cells and Macrophages to Cancer. Hashimoto K; Honda K; Matsui H; Nagashima Y; Oda H Anticancer Res; 2016 Jul; 36(7):3579-84. PubMed ID: 27354626 [TBL] [Abstract][Full Text] [Related]
57. SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation. Redin E; Garmendia I; Lozano T; Serrano D; Senent Y; Redrado M; Villalba M; De Andrea CE; Exposito F; Ajona D; Ortiz-Espinosa S; Remirez A; Bertolo C; Sainz C; Garcia-Pedrero J; Pio R; Lasarte J; Agorreta J; Montuenga LM; Calvo A J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33658304 [TBL] [Abstract][Full Text] [Related]
58. The exosomal integrin α5β1/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration. Li X; Tang M; Zhu Q; Wang X; Lin Y; Wang X Cell Oncol (Dordr); 2020 Apr; 43(2):263-277. PubMed ID: 32080801 [TBL] [Abstract][Full Text] [Related]
59. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells. Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875 [TBL] [Abstract][Full Text] [Related]
60. Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. Nam S; Kim D; Cheng JQ; Zhang S; Lee JH; Buettner R; Mirosevich J; Lee FY; Jove R Cancer Res; 2005 Oct; 65(20):9185-9. PubMed ID: 16230377 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]